- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 6.88M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $159K |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $181K |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $88K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $87K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $10.22M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $12.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $4.93M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $6.14M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.09M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $6.32M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $19.47M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $19.99M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $31.08M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $31.69M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $35.44M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 6.81M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $70K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.04M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $25M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $26.2M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.26M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $746K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.47M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.62M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $797K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $4.13M |
| Revenue | Q1 2025 · Mar 31, 2024 | $4.92M |